Jiayang Xie

Jiayang Xie

Auto-generated profile, based on publicly available information

Jiayang Xie

State Key Laboratory of Bioreactor Engineering, East China University of Science and Technology, Shanghai 200237, China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 February 2020 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
Min ZhouMin Zhou
Min Zhou
YQYuxin Qian
Yuxin Qian
JXJiayang Xie
Jiayang Xie
WZWenjing Zhang
Wenjing Zhang
WJWeinan Jiang
Weinan Jiang
Runhui LiuRunhui Liu
Runhui Liu

27 January 2023 in Science Advances
Verified
Journal Article
Closed access
HZHaodong Zhang
Haodong Zhang
QCQi Chen
Qi Chen
JXJiayang Xie
Jiayang Xie
ZCZihao Cong
Zihao Cong
CCChuntao Cao
Chuntao Cao
Runhui LiuRunhui Liu
Runhui Liu
Drug-resistant bacterial infections have caused serious threats to human health and call for effective antibacterial agents that have low propensity to induce antimicrobial resistance. Host defense peptide–mimicking peptides are actively explored, among which poly-β- l -lysine displays potent antibacterial activity but high cytotoxicity due to the helical structure and strong membrane disruption effect. Here, we report an effective strategy to optimize antimicrobial peptides by switching membrane disrupting to membrane penetrating and intracellular targeting by breaking the helical structure using racemic residues. Introducing β-homo-glycine into poly-β-lysine effectively reduces the toxicity of resulting poly-β-peptides and affords the optimal poly-β-peptide, βLys 50 HG 50 , which shows potent antibacterial activity against clinically isolated methicillin-resistant Staphylococcus aureus (MRSA) and MRSA persister cells, excellent biosafety, no antimicrobial resistance, and strong therapeutic potential in both local and systemic MRSA infections. The optimal poly-β-peptide demonstrates strong therapeutic potential and implies the success of our approach as a generalizable strategy in designing promising antibacterial polypeptides.

18 March 2019 in Biomaterials Science
Verified
Journal Article
Closed access
PDF file
QZQiang Zhang
Qiang Zhang
PMPengcheng Ma
Pengcheng Ma
JXJiayang Xie
Jiayang Xie
SZSi Zhang
Si Zhang
XXXimian Xiao
Ximian Xiao
Runhui LiuRunhui Liu
Runhui Liu
Poly-β-peptide 20 : 80 Bu : DM displays broad spectrum antibacterial activities, rapid bacterial killing and no susceptibility to antimicrobial resistance.

19 February 2022 in Angewandte Chemie International Edition
Verified
Journal Article
Closed access
PDF file
WJWeinan Jiang
Weinan Jiang
Min ZhouMin Zhou
Min Zhou
ZCZihao Cong
Zihao Cong
JXJiayang Xie
Jiayang Xie
WZWenjing Zhang
Wenjing Zhang
Runhui LiuRunhui Liu
Runhui Liu

7 May 2019 in ACS Applied Materials & Interfaces
Verified
Journal Article
Closed access
FQFan Qi
Fan Qi
YQYuxin Qian
Yuxin Qian
NSNing Shao
Ning Shao
RZRuiyi Zhou
Ruiyi Zhou
SZSi Zhang
Si Zhang
Runhui LiuRunhui Liu
Runhui Liu

15 November 2023 in Journal of the American Chemical Society
Verified
Journal Article
Closed access
WJWeinan Jiang
Weinan Jiang
Min ZhouMin Zhou
Min Zhou
SCSheng Chen
Sheng Chen
JXJiayang Xie
Jiayang Xie
MCMinzhang Chen
Minzhang Chen
Runhui LiuRunhui Liu
Runhui Liu